Potter Clarkson underlines firmwide growth with new hires
Following a period of continued growth, Potter Clarkson has made two new senior hires to join its respected team of IP professionals.
SEARCH
Showing 954 Results
Amgen v Sanofi: narrowing the scope of protection for antibody inventions?
In the latest development in global patent litigation that has polarized the life sciences industry, Amgen’s patent claims covering a whole class of monoclonal antibody PCSK9 inhibitors have been ruled to be invalid by the US Court of Appeals for the Federal Circuit.
White paper: Maximising the commercial value of digital therapeutics
In this white paper we share what we have found while helping brand-new digital therapeutics ventures define, commercialise, and protect their ideas. We also highlight and tackle the likely obstacles they will need to overcome as they race to take their products to market.
World Intellectual Property Day 2021
This year, World Intellectual Property Day is focused on supporting SMEs in taking their ideas to market. To celebrate the creativity, ingenuity and brilliance of innovators around the world, we are showcasing some of the great ideas that turned into global success stories.
Potter Clarkson adds further weight to ‘best in class’ offer with new litigation & licensing partner
Mark Kramer has joined Potter Clarkson to head up the firm’s London litigation & licensing team, further strengthening its growing practice in both the UK and Europe.
Getting a grip on plastics sustainability today and tomorrow
Plastic is often referred to as the material of the 20th century. However, in recent years, the reputation of plastics has been tainted due to largely poor degradation and reusability. The latest innovations and scientific developments were highlighted at the recent Global Research & Innovation in Plastics Sustainability (GRIPS) virtual conference.